Meditrina Inc

Meditrina Inc is a privately held medical device company based in San Jose, California, founded in 2016. The company specializes in developing innovative, minimally invasive gynecologic medical devices, particularly advanced hysteroscopy systems aimed at improving the diagnosis and treatment of uterine conditions like endometrial polyps and uterine fibroids. The flagship product, the Aveta™ hysteroscopy suite, is an all-in-one platform designed for use in operating, procedure, or exam rooms. It includes the Aveta™ Pearl Hysteroscope, a single-use device for myomectomy procedures, and the Aveta™ Coral Hysteroscope, intended for polypectomy procedures. Both devices feature integrated fluid management and video control capabilities, enhancing physician control during procedures. Meditrina's products support various in-office and clinic-based procedures, promoting minimally invasive treatment options that improve patient outcomes. The company has achieved significant regulatory milestones, including CE Mark and UKCA Mark approvals in 2024, allowing entry into European and UK markets. Meditrina serves healthcare providers specializing in gynecology, focusing on empowering physicians with advanced tools for uterine diagnostics and treatment.

• Employees 130
• Founded 2016
• Total Funding $48000000